PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportstobacco use disorder
MeSH D014029 - tobacco use disorder
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D019966:Substance-related disorders
10 Companies
2 Drugs
$
Success rate
D014029: 
Tobacco use disorder
58 Companies
6 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaNicotine polacrilex Nicotine Polacrilex  2009-02-18   
Rising PharmaceuticalsBupropion Bupropion  2010-05-03   
PerrigoNicotine polacrilex Nicotine Polacrilex  2004-09-16   
P&L Developments (PLD)Nicotine polacrilex Nicotine Polacrilex  1999-03-15   
GSKNicotine polacrilex Nicorette 2028-04-30 1996-02-09   
Nicotine polacrilex Thrive  2007-06-19   
Bupropion Wellbutrin  1985-12-30   
Bupropion Zyban  1997-05-14   
CiplaBupropion Bupropion  2016-08-26   
Lupin ResearchBupropion Bupropion  2017-04-06   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
55%
18/33
Phase 2
21%
8/38
Phase 3
62%
8/13
Approved: 4Overall Success rate: 7%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Nicotine polacrilex
Mylan
Citalopram
GSK
Bupropion,
Nicotine polacrilex,
Levosalbutamol,
Corticoids,
Nrt,
GSK598809,
Gw468816,
Wellbutrin,
Nmda,
Zyban,
Nicoderm
Lupin Research
Bupropion
Sandoz
Bupropion
Sanofi
Nicotine,
Nicotine polacrilex
Bausch Health Companies
Bupropion
Pfizer
Nicotine,
Nicotine polacrilex,
Benzocaine,
Cytisinicline,
Ademetionine,
Aspartame,
Nrt,
Hookah,
Wellbutrin,
Zyban,
Nicoderm
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use